Nevertheless, our established protocol of sequential stimulation and inhibition of LPAR4 signaling could efficiently trigger cardiac tissue repair after MI, suggesting a possible imminent implementation in clinical practice. The gene discussed is LPAR4; the disease is myocardial infarction.